All In Biotech

Drug Trial Radar · NCT00148278

Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock

Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock.

Last checked: Nov 19, 2026Latest source record: Jul 22, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 330 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

330

Actual

Start

Oct 1999

Primary completion

Dec 2004

Study completion Dec 2005

Sponsor

Lead sponsor
University of VersaillesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Assistance Publique - Hôpitaux de Paris
First posted
Sep 7, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Catecholamines infusion is a major component of septic shock management. International guidelines recommend that norepinephrine should be preferred to epinephrine, though phase III trials are lacking. The present study aimed at comparing the efficacy and safety of norepinephrine plus dobutamine to that of epinephrine in adults with septic shock.

Conditions

  • Septic Shock
  • Severe Sepsis
  • Infections

Interventions

  • norepinephrine and dobutamineDrug

    continuous infusion of norepinephrine titrated to maintain a mean arterial pressure at 70mmHg or more and dobutamine could be added as a continuous infusion when cardiac index was of less than 2.5 liters per squared meter of body surface

  • epinephrine plus placebo of dobutamineDrug

    epinephrine was titrated to maintain a mean arterial pressure at 70mmHg or more and placebo of dobutamine was titrated in case of a cardiac index lower than 2.5 liters per squared meters of body surface

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 28 Day mortalityTime frame: 28 Day

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Réanimation Médicale - Hôpital Louis Mourier

    Colombes, France

  • Réanimation Polyvalente - Hôpital de Corbeil

    Corbeil, France

  • Service de Réanimation Médicale - Hôpital Poincaré

    Garches, France

  • Réanimation Médicale - Hôpital André Mignot

    Le Chesnay, France

  • Réanimation Polyvalente - Hôpital Dupuytren

    Limoges, France

  • Réanimation Polyvalente - Hôpital Nord

    Marseille, France

  • Réanimation Chirurgicale - Hôpital Central

    Nancy, France

  • Service de Réanimation Médicale - Hôpital Central

    Nancy, France

  • Service d'anesthésiologie - HIA Val de Grâce

    Paris, France

  • Réanimation Médicale - Hôpital Saint Louis

    Paris, France

  • Réanimation Polyvalente - Hôpital Saint Joseph

    Paris, France

  • Réanimation Médicale - Hôpital Georges Pompidou

    Paris, France

  • Réanimation Médicale - CHI de Poissy

    Poissy, France

  • Réanimation - CH Victor Provo

    Roubaix, France

  • Réanimation Polyvalente - Institut Gustave Roussy

    Villejuif, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.